Soluble Ferric Pyrophosphate: Completed Phase IIb enrollment

Rockwell completed enrollment of about 130 patients in a double-blind, placebo-controlled, U.S. and Canadian Phase IIb trial evaluating 5, 10, 12 or 15 µg/dL of SFP in dialysate given during thrice-we...